StockData
Adaptive Biotechnologies Corp logo

Adaptive Biotechnologies Corp (ADPT) stock

ADPTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30
$28.49+0.62 (+2.22%)

Close on Nov 17, 2026Market cap $4.55BP/E –Yield –

Adaptive Biotechnologies price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Adaptive Biotechnologies's price to book ratio was 33.3× on Nov 11, 2026, against 14.7× a year earlier. Over the last 5 years it ranged from 1.2× to 33.3×, with a median of 3.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202633.3×+21.2
2025Dec 31, 202512.1×+8.2
2024Dec 31, 20244.0×+2.0
2023Dec 29, 20232.0×−0.3
2022Dec 30, 20222.2×−3.8
2021Dec 31, 20216.1×−4.3
2020Dec 31, 202010.4×+4.1
2019Dec 31, 20196.3×–

More Adaptive Biotechnologies figures

See a number that looks wrong?